Amyloid PET Screening for Enrichment of Early-Stage Alzheimer Disease Clinical TrialsJeff Sevigny, Jerome Barakos, Joonmi Oh et al.|Alzheimer Disease & Associated Disorders|2016Cited by 115
Treatment of internuclear ophthalmoparesis in multiple sclerosis with fampridine: A randomized double‐blind, placebo‐controlled cross‐over trialKawita M. S. Kanhai, Geert Jan Groeneveld, Laurentius J. van Rijn et al.|CNS Neuroscience & Therapeutics|2019Cited by 20
O4‐07‐02: ENRICHMENT OF EARLY‐STAGE AD PATIENT RECRUITMENT TO A PHASE IB STUDY (221AD103) THROUGH AMYLOID PET SCREENING BY APOE ɛ4 STATUSPing Chiao, Jeff Sevigny, Joyce Suhy et al.|Alzheimer s & Dementia|2014Cited by 1